entertainment -WSS

entertainment

author：knowledge 2025-09-27 09:46:55 - browse：77

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Humana CEO Bruce Broussard to step down in 2024

entertainment

WSS

How clinical AI models' predictive power can degrade over time

Akero's treatment for NASH falls short in cirrhosis study

European regulators recommend Amylyx's ALS drug be rejected

Superbugs, antibiotic resistance get scrutiny in congress

Digital health funding stays low as a new reality sets in

Wellcome Trust names Røttingen as its new CEO

hotspot

entertainment

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Medical leaders decry Supreme Court decision on affirmative action

Inflation cooled significantly in June, bringing price hikes close to normal levels

Jerome Adams on the need for new antivirals for Covid

Superbugs, antibiotic resistance get scrutiny in congress

United colonoscopy coverage change 'may cost lives,' doctors say

Britney Spears to release memoir, 'The Woman In Me,' later this year

Wildfire smoke exposes gaps in outdoor worker protections

Women's World Cup brings attention to abuse in soccer

entertainment

European regulators recommend Amylyx's ALS drug be rejected

Inflation cooled significantly in June, bringing price hikes close to normal levels

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Researchers CRISPR chickens in bid to protect them from bird flu

The debate over Covid

Companies helping big Covid

Wikipedia

entertainment

Wikipedia

hotspot